Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function
Authors:
- 12 September 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 374 (1) , 138-142
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected CellsJournal of Virology, 2008
- The SARS-Coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding proteinVirus Research, 2008
- Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolinJournal of General Virology, 2007
- Derivation of a novel SARS–coronavirus replicon cell line and its application for anti-SARS drug screeningVirology, 2007
- Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysisJournal of General Virology, 2006
- Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesisProceedings of the National Academy of Sciences, 2006
- Role of Nucleotides Immediately Flanking the Transcription-Regulating Sequence Core in Coronavirus Subgenomic mRNA SynthesisJournal of Virology, 2005
- Identification and Characterization of Severe Acute Respiratory Syndrome Coronavirus Replicase ProteinsJournal of Virology, 2004
- Sequence Motifs Involved in the Regulation of Discontinuous Coronavirus Subgenomic RNA SynthesisJournal of Virology, 2004
- Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirusProceedings of the National Academy of Sciences, 2003